James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

10 Small-Cap, Up-And-Coming Stocks to Keep on Your Radar

Qorvo, Catalent and XPO Logistics are just some of the up-and-coming stocks too many investors are still overlooking.

10 Marijuana Stocks That Could See 100% Gains, If Not More

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.

Stock Market Today: Beyond Meat Makes a Friend on Wall Street

Apple's health initiative can't keep key people and Sarepta Therapeutics' CLR are a couple more top news items about the stock market today.

The 10 Best Cheap Stocks to Buy Right Now

Micron, Citigroup and General Motors are just some of the cheap stocks that investors may want to consider for their portfolio here.

3 Big Stock Charts for Tuesday: Twitter, Lowe’s and Procter & Gamble

The stock charts of Twitter, Lowe's and Procter & Gamble merit a closer technical look as the trading week marches on.